TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria

Clinical trial NCT05883176 · UNKNOWN

Trial details

NCT number: NCT05883176
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma by BCLC Stage

Start date: 2023-06-01
Primary completion: 2025-05-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.